These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
513 related articles for article (PubMed ID: 10474521)
41. Expression of cytokeratin 20 in mucinous bronchioloalveolar carcinoma. Shah RN; Badve S; Papreddy K; Schindler S; Laskin WB; Yeldandi AV Hum Pathol; 2002 Sep; 33(9):915-20. PubMed ID: 12378517 [TBL] [Abstract][Full Text] [Related]
42. Colonic adenocarcinoma metastatic to the thyroid gland: a case report with immunohistochemical investigation. Kim CH; Park YW; Ayala AG; Ro JY J Korean Med Sci; 1999 Aug; 14(4):455-9. PubMed ID: 10485629 [TBL] [Abstract][Full Text] [Related]
43. Sinonasal adenocarcinoma: evidence for histogenetic divergence of the enteric and nonenteric phenotypes. Choi HR; Sturgis EM; Rashid A; DeMonte F; Luna MA; Batsakis JG; El-Naggar AK Hum Pathol; 2003 Nov; 34(11):1101-7. PubMed ID: 14652810 [TBL] [Abstract][Full Text] [Related]
44. CK7, CK20, CDX2 and MUC2 Immunohistochemical staining used to distinguish metastatic colorectal carcinoma involving ovary from primary ovarian mucinous adenocarcinoma. Shin JH; Bae JH; Lee A; Jung CK; Yim HW; Park JS; Lee KY Jpn J Clin Oncol; 2010 Mar; 40(3):208-13. PubMed ID: 19926591 [TBL] [Abstract][Full Text] [Related]
45. [Serous cystadenocarcinoma of the ovary with simultaneous breast metastases. Description of a case]. Manini C; Pietribiasi F; Sapino A; Donadio S Pathologica; 1998 Apr; 90(2):152-5. PubMed ID: 9619059 [TBL] [Abstract][Full Text] [Related]
46. Cytokeratin 7 immunoreactivity in rectal adenocarcinomas. Zhang PJ; Shah M; Spiegel GW; Brooks JJ Appl Immunohistochem Mol Morphol; 2003 Dec; 11(4):306-10. PubMed ID: 14663355 [TBL] [Abstract][Full Text] [Related]
47. Utility of thyroid transcription factor-1 and cytokeratin 7 and 20 immunostaining in the identification of origin in malignant effusions. Jang KY; Kang MJ; Lee DG; Chung MJ Anal Quant Cytol Histol; 2001 Dec; 23(6):400-4. PubMed ID: 11777274 [TBL] [Abstract][Full Text] [Related]
49. Utility of cytokeratin immunostaining in separating pulmonary adenocarcinomas from colonic adenocarcinomas. Loy TS; Calaluce RD Am J Clin Pathol; 1994 Dec; 102(6):764-7. PubMed ID: 7528468 [TBL] [Abstract][Full Text] [Related]
50. Thyroid transcription factor-1 and cytokeratins 7 and 20 in pulmonary and breast carcinoma. Harlamert HA; Mira J; Bejarano PA; Baughman RP; Miller MA; Whitsett JA; Yassin R Acta Cytol; 1998; 42(6):1382-8. PubMed ID: 9850647 [TBL] [Abstract][Full Text] [Related]
51. Distinction between endometrial and endocervical adenocarcinoma: an immunohistochemical study. Castrillon DH; Lee KR; Nucci MR Int J Gynecol Pathol; 2002 Jan; 21(1):4-10. PubMed ID: 11781516 [TBL] [Abstract][Full Text] [Related]
52. The usefulness of CDX-2 for differentiating primary and metastatic ovarian carcinoma: an immunohistochemical study using a tissue microarray. Kim MJ J Korean Med Sci; 2005 Aug; 20(4):643-8. PubMed ID: 16100458 [TBL] [Abstract][Full Text] [Related]
53. Immunohistochemical identification of tumor markers in metastatic adenocarcinoma. A diagnostic adjunct in the determination of primary site. Brown RW; Campagna LB; Dunn JK; Cagle PT Am J Clin Pathol; 1997 Jan; 107(1):12-9. PubMed ID: 8980361 [TBL] [Abstract][Full Text] [Related]
54. Role of TTF-1, CK20, and CK7 immunohistochemistry for diagnosis of primary and secondary lung adenocarcinoma. Su YC; Hsu YC; Chai CY Kaohsiung J Med Sci; 2006 Jan; 22(1):14-9. PubMed ID: 16570563 [TBL] [Abstract][Full Text] [Related]
55. Immunohistochemical expression of CDX2 in primary ovarian mucinous tumors and metastatic mucinous carcinomas involving the ovary: comparison with CK20 and correlation with coordinate expression of CK7. Vang R; Gown AM; Wu LS; Barry TS; Wheeler DT; Yemelyanova A; Seidman JD; Ronnett BM Mod Pathol; 2006 Nov; 19(11):1421-8. PubMed ID: 16980943 [TBL] [Abstract][Full Text] [Related]
56. Adenocarcinomas metastatic to the liver: the value of cytokeratins 20 and 7 in the search for unknown primary tumors. Tot T Cancer; 1999 Jan; 85(1):171-7. PubMed ID: 9921990 [TBL] [Abstract][Full Text] [Related]
57. Colon signet ring cell adenocarcinoma: immunohistochemical characterization and comparison with gastric and typical colon adenocarcinomas. Goldstein NS; Long A; Kuan SF; Hart J Appl Immunohistochem Mol Morphol; 2000 Sep; 8(3):183-8. PubMed ID: 10981869 [TBL] [Abstract][Full Text] [Related]
58. Cytokeratins, CEA, and mucin histochemistry in the diagnosis and characterization of extramammary Paget's disease. Battles OE; Page DL; Johnson JE Am J Clin Pathol; 1997 Jul; 108(1):6-12. PubMed ID: 9208972 [TBL] [Abstract][Full Text] [Related]
59. [A clinicopathological study of perianal Paget's disease associated with internal rectal adenocarcinoma]. Liu CF; Wang Q; Kong YY; Tu XY; Wang J; Zhu XZ Zhonghua Bing Li Xue Za Zhi; 2004 Feb; 33(1):11-5. PubMed ID: 14989921 [TBL] [Abstract][Full Text] [Related]
60. Primary cervical adenocarcinoma with intestinal differentiation and colonic carcinoma metastatic to cervix: an investigation using Cdx-2 and a limited immunohistochemical panel. Raspollini MR; Baroni G; Taddei A; Taddei GL Arch Pathol Lab Med; 2003 Dec; 127(12):1586-90. PubMed ID: 14632574 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]